These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines. Nwaka S Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S20-9. PubMed ID: 16085175 [TBL] [Abstract][Full Text] [Related]
3. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings. Russo G; McPake B Health Policy Plan; 2010 Jan; 25(1):70-84. PubMed ID: 19843636 [TBL] [Abstract][Full Text] [Related]
4. Poverty and access to health care in developing countries. Peters DH; Garg A; Bloom G; Walker DG; Brieger WR; Rahman MH Ann N Y Acad Sci; 2008; 1136():161-71. PubMed ID: 17954679 [TBL] [Abstract][Full Text] [Related]
5. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world. Hale VG; Woo K; Lipton HL Health Aff (Millwood); 2005; 24(4):1057-63. PubMed ID: 16012146 [TBL] [Abstract][Full Text] [Related]
6. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain. James JS AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151 [TBL] [Abstract][Full Text] [Related]
7. The morally uncomfortable global drug gap. Cohen-Kohler JC Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710 [TBL] [Abstract][Full Text] [Related]
8. Poverty, health & intellectual property rights with special reference to India. Satyanarayana K; Srivastava S Indian J Med Res; 2007 Oct; 126(4):390-406. PubMed ID: 18032814 [TBL] [Abstract][Full Text] [Related]
9. Differential pricing of new pharmaceuticals in lower income European countries. Kaló Z; Annemans L; Garrison LP Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):735-41. PubMed ID: 24219049 [TBL] [Abstract][Full Text] [Related]
10. [Access for all to quality drugs]. Videau JY Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178 [TBL] [Abstract][Full Text] [Related]
11. The Health Impact Fund: incentives for improving access to medicines. Banerjee A; Hollis A; Pogge T Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894 [No Abstract] [Full Text] [Related]
12. Market-based licensing for HPV vaccines in developing countries. Outterson K; Kesselheim AS Health Aff (Millwood); 2008; 27(1):130-9. PubMed ID: 18180488 [TBL] [Abstract][Full Text] [Related]
13. U.S. blocks trade agreement on generic drug access in poor countries. James JS AIDS Treat News; 2002 Dec; (386):4-6. PubMed ID: 12569874 [TBL] [Abstract][Full Text] [Related]
14. Public-private partnerships: an overview. Widdus R Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S1-8. PubMed ID: 16085172 [TBL] [Abstract][Full Text] [Related]
15. Providing affordable essential medicines to African households: the missing policies and institutions for price containment. Tetteh Ek Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953 [TBL] [Abstract][Full Text] [Related]
16. [Quality of medicines in least developed countries]. Videau JY Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015 [TBL] [Abstract][Full Text] [Related]
17. Medicines for the world: a way forward. James JS AIDS Treat News; 2004 Mar; (399):7-8. PubMed ID: 15199870 [TBL] [Abstract][Full Text] [Related]
18. Commentary: will generic drug stores improve access to essential medicines for the poor in India? Kotwani A J Public Health Policy; 2010 Jul; 31(2):178-84. PubMed ID: 20535100 [No Abstract] [Full Text] [Related]
19. Improving access to drugs by poor households through a cost sharing drug scheme: a wealth ranking approach. Karkee SB; Tamang AL; Gurung YB; Mishra G; Banez-Ockelford J; Saunders P; Rai C Nepal Med Coll J; 2005 Jun; 7(1):26-31. PubMed ID: 16295717 [TBL] [Abstract][Full Text] [Related]
20. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards. Cohen-Kohler JC; Forman L; Lipkus N Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]